Abstract
Pituitary adenylate cyclase activating polypeptide (PACAP) is widely distributed in ocular tissues, including the lacrimal gland. PACAP has been shown to influence the activity of several exocrine glands, but its effects on the composition of the tear film are not known yet. Similarly, the presence of PACAP has already been shown in the inner ear, but it is not known whether PACAP influences the composition of the endolymph. The aim of the present study was to investigate whether systemic injection of PACAP has any modulatory effects on the protein composition of the tear film and endolymph using chip electrophoresis and mass spectrometry analysis. Tear and endolymph samples were collected from rats and chickens, respectively, at various time points after systemic injection of PACAP. Fluid samples were further processed for chip electrophoretic studies. No difference was found in the protein composition of the endolymph between control and PACAP-treated animals. In contrast, tear samples showed a marked difference after PACAP treatment. Proteins in the molecular range 50–70 kDa, which showed a different chip electropherogram profile in every PACAP-treated sample, were further analyzed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. PACAP treatment induced a repression in certain keratins, while others were induced after PACAP injection. Furthermore, PACAP treatment decreased aldehyde dehydrogenase expression. The present study provides a base for further studies on the in vivo effects of PACAP on the composition of tear film. These investigations may have important clinical relevance because of the noninvasive sample collection, the correlation between tear proteins and ocular diseases, and the possible presence of biomarkers for both ophthalmological and systemic pathological conditions.
Similar content being viewed by others
References
Abu-Hamdan, M. D., Drescher, M. J., Ramakrishnan, N. A., et al. (2006). Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: Evidence for specific transcript expression of PAC1-R splice variants in rat miscrodissected cochlear subfractions. Neuroscience, 140, 147–161.
Babai, N., Atlasz, T., Tamas, A., Reglodi, D., Kiss, P., & Gabriel, R. (2005). Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retina degeneration. Neurotoxicity Research, 8, 227–233.
Baker, G. R., Morton, M., Rajapaska, R. S., et al. (2006). Altered tear composition in smokers and patients with Graves ophthalmopathy. Archives of Ophthalmology, 124, 1451–1456.
Borba, J. C., Henze, I. P., Silveira, M. S., et al. (2005). Pituitary adenylate cyclase activating polypeptide (PACAP) can act as determinant of the tyrosine hydoxylase phenotype of dopaminergic cells during retina development. Developmental Brain Research, 156, 193–201.
Calvert, P. A., Heck, P. M., & Edwards, A. V. (1998). Autonomic control of submandibular protein secretion in the anaesthetized calf. Experimental Physiology, 83, 545–556.
Couloigner, V., Teixeira, M., Sterkers, O., Rask-Andersen, H., & Ferrary, E. (2004). The endolymphatic sac: its roles in the inner ear. Medical Science (Paris), 20, 304–310.
De Souza, G. A., Godoy, L. M., & Mann, M. (2006). Identification of 491 proteins in the tear fluid proteome reveals a large number if proteases and protease inhibitors. Genome Biology, 7, R72.
Drescher, M. J., Drescher, D. G., Khan, K. M., et al. (2006). Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor (PAC-1R) are positioned to modulate afferent signaling in the cochlea. Neuroscience, 142, 139–164.
Eckert, R. L., & Green, H. (1984). Cloning of cDNAs specifying vitamin A-responsive human keratins. Proceedings of the National Academy of Sciences of the United States of America, 81, 4321–4325.
Elsas, T., Uddman, R., & Sundler, F. (1996). Pituitary adenylate cyclase activating peptide-immunoreactive nerve fibers in the cat eye. Graefe's Archive for Clinical and Experimental Ophthalmology, 234, 573–580.
Ferrary, E., Bernard, C., Teixeira, M., et al. (1996). Hormonal modulation of inner ear fluids. Acta Oto-laryngologica, 116, 244–247.
Ferrary, E., & Sterkers, O. (1998). Mechanisms of endolymph secretion. Kidney International Supplement, 65, S98–S103.
Fukushima, K., Takeda, T., Kakigi, A., et al. (2005). Effects of lithium on endolymph homeostasis and experimentally induced endolymphatic hydrops. ORL Journal for Oto-rhino-laryngoly and its Related Specialties, 67, 282–288.
Gilbard, J. P., Rossi, S. R., Heyda, K. G., & Dartt, D. A. (1990). Stimulation of tear secretion by topical agents that increase cyclic nucleotide levels. Investigative Ophthalmology in Visual Science, 31, 1381–1388.
Grus, F. H., Podust, V. N., Bruns, K., et al. (2005). SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye. Investigative Ophthalmology in Visual Science, 46, 863–876.
Hanner, P., Jennische, E., Lange, S., Lonnroth, I., & Wahlstrom, B. (2004). Increased antisecretory factor reduces vertigo in patients with Meniere’s disease: A pilot study. Hearing Research, 190, 31–36.
Hannibal, J., & Fahrenkrug, J. (2004). Target areas innervated by PACAP-immunoreactive retinal ganglion cells. Cell & Tissue Research, 316, 99–113.
Hu, S., Loo, J. A., & Wong, D. T. (2006). Human body fluid proteome analysis. Proteomics, 6, 6326–6353.
Jozsa, R., Somogyvari-Vigh, A., Reglodi, D., Hollosy, T., & Arimura, A. (2001). Distribution and daily variations of PACAP in the chicken brain. Peptides, 22, 1371–1377.
Kamaishi, H., Endoh, T., & Suzuki, T. (2004). Multiple signal pathways coupling VIP and PACAP receptors to calcium channels in hamster submandibular ganglion neurons. Autonomic Neuroscience, 111, 15–26.
Kapicioglu, Z., Kalyoncu, I. N., Deger, O., & Can, G. (1998). Effect of a somatostatin analogue (SMS 201-995) on tear secretion in rats. International Ophtalmology, 22, 43–45.
Kawano, H., Shimozono, M., Tono, T., Miyata, A., & Komune, S. (2001). Expression of pituitary adenylate cyclase activating polypeptide mRNA in the cochlea of rats. Molecular Brain Research, 94, 200–203.
Kawasaki, S., Tanioka, H., Yamasaki, K., Yokoi, N., Komuro, A., & Kinoshita, S. (2006). Clusters of corneal epithelial cells reside ectopically in human conjunctival epithelium. Investigative Ophthalmology in Visual Science, 47, 1359–1367.
Kays, W. T., & Piatigorsky, J. (1997). Aldehyde dehydrogenase class 3 expression: identification of a cornea-preferred gene promoter in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 94, 13594–13599.
Kitano, H., Suzuki, M., Kitanishi, T., et al. (1999). Regulation of inner ear fluid in the rat by vasopressin. Neuroreport, 10, 1205–1207.
Kovacs, I., Ludany, A., Koszegi, T., et al. (2005). Substance P released from sensory nerve endings influences tear secretion and goblet cell function in the rat. Neuropeptides, 39, 395–402.
Kurpakus, M. A., Stock, E. L., & Jones, J. C. (1990). Expression of the 55-kD–64-kD corneal keratins in ocular surface epithelium. Investigative Ophthalmology in Visual Science, 31, 448–456.
Kustos, I., Andrasfalvy, M., Kustos, T., Kocsis, B., & Kilar, F. (2005). Effect of iron restriction on outer membrane protein composition of Pseudomonas strains studied by conventional and microchip electrophoresis. Electrophoresis, 26, 3789–3795.
Lebon, A., Seyer, D., Cosette, P., et al. (2006). Identification of proteins regulated by PACAP in PC12 cells by 2D gel electrophoresis coupled to mass spectrometry. Annals of the New York Academy of Sciences, 1070, 380–387.
Li, N., Wang, N., Zheng, J., et al. (2005). Characterization of human tear proteome using multiple proteomic analysis techniques. Journal in Proteome Research, 4, 2052–2061.
Mirfendereski, S., Tobin, G., Hakanson, R., & Ekstrom, J. (1997). Pituitary adenylate cyclase activating peptide (PACAP) in salivary glands of the rat: origin, and secretory and vascular effects. Acta Physiologica Scandinavica, 160, 15–22.
Nagano, T., Nakamura, M., Nakata, K., et al. (2003). Effects of substance P and IGF-1 in corneal epithelial barrier function and wound healing in a rat model of neurotrophic keratopathy. Investigative Ophthalmology in Visual Science, 44, 3810–3815.
Nakatani, M., Seki, T., Shinohara, Y., et al. (2006). Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates production of interleukin-6 in rat Muller cells. Peptides, 27, 1871–1876.
Nilsson, S. F. (1994). PACAP-27 and PACAP-38: Vascular effects in the eye and some other tissues in the rabbit. European Journal of Pharmacology, 253, 17–25.
Nilsson, S. F., De Neef, P., Robberecht, P., & Christophe, J. (1994). Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase. Experimental Eye Research, 58, 459–467.
Pedersen, A. M., Dissing, S., Fahrenkrug, J., Hannibal, J., Reibel, J., & Nauntofte, B. (2000). Innervation pattern and Ca2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjogren’s syndrome (pSS). Journal of Oral Pathology & Medicine, 29, 97–109.
Pei, Y., Reins, R. Y., & McDermott, A. M. (2006). Eldehyde dehydrogenase (ALDH) 3A1 expression by the human keratocyte and its repair phenotypes. Experimental Eye Research, 83, 1063–1073.
Peterfi, Z., Kustos, I., Kilar, F., & Kocsis, B. (2007). Microfluidic chip analysis of outer membrane proteins responsible for serological cross-reaction between three Gram-negative bacteria: Proteus morganii O34, Escherichia coli O111 and Salmonella adelaide O35. Journal of Chromatography, 1155, 214–217.
Porter, M. R., & Lane, E. B. (2003). Phenotypes, genotypes and their contribution to understanding keratin function. Trends in Genetics, 19, 278–285.
Racz, B., Gallyas Jr., F., Kiss, P., et al. (2006). The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involves inhibition of proapoptotic signaling pathways. Regulatory Peptides, 137, 20–26.
Racz, B., Gallyas Jr., F., Kiss, P., et al. (2007). Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats. Neurotoxicity Research, 12, 95–104.
Raphael, Y., & Altschuler, R. A. (2003). Structure and innervation of the cochlea. Brain Research Bulletin, 60, 397–422.
Reglodi, D., Somogyvari-Vigh, A., Vigh, S., Kozicz, T., & Arimura, A. (2000). Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke, 31, 1411–1417.
Reglodi, D., Tamas, A., Somogyvári-Vigh, A., et al. (2002). Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides, 23, 2227–2234.
Seki, T., Izumi, S., Shioda, S., Zhou, C. J., Arimura, A., & Koide, R. (2000b). Gene expression for PACAP receptor mRNA in the rat retina by in situ hybridization and in situ RT-PCR. Annals of the New York Academy of Sciences, 921, 366–369.
Seki, T., Shioda, S., Izumi, S., Arimura, A., & Koide, R. (2000a). Electron microscopic observation of pituitary adenylate cyclase activating polypeptide (PACAP)-containing neurons in the rat retina. Peptides, 21, 109–113.
Shioda, S., Ohtaki, H., Nakamachi, T., et al. (2006). Pleiotropic functions of PACAP in the CNS. Neuroprotection and neurodevelopment. Annals of the New York Academy of Sciences, 1070, 550–560.
Shoge, K., Mishima, H. K., Saitoh, T., et al. (1999). Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons. Brain Research, 839, 66–73.
Skakkabaek, M., Hannibal, J., & Fahrenkrug, J. (1999). Pituitary adenylate cyclase activating polypeptide (PACAP) in the rat mammary gland. Cell & Tissue Research, 298, 153–159.
Somogyvari-Vigh, A., & Reglodi, D. (2004). Pituitary adenylate cyclase activating polypeptide: A potential neuroprotective peptide. Review of Current Pharmaceutical Design, 10, 2861–2889.
Tanaka, K., & Smith, C. A. (1978). Structure of the chicken’s inner ear: SEM and TEM study. American Journal of Anatomy, 153, 251–271.
Thalmann, R., & Thalmann, I. (1999). Source and role of endolymph macromolecules. Acta Oto-laryngologica, 119, 293–296.
Tobin, G., Asztely, A., Edwards, A. V., Ekstrom, J., Hakanson, R., & Sundler, F. (1995). Presence and effects of pituitary adenylate cyclase activating peptide in the submandibular gland of the ferret. Neuroscience, 66, 227–235.
Tomosugi, N., Kitagawa, K., Takahashi, N., Sugai, S., & Ishikawa, I. (2005). Diagnostic potential of tear proteomic patters in Sjogren’s syndrome. Journal of Proteome Research, 4, 820–825.
Vaudry, D., Gonzalez, B. J., Basille, M., Yon, L., Fournier, A., & Vaudry, H. (2000). Pituitary adenylate cyclase activating polypeptide and its receptors: From structure to functions. Pharmacological Reviews, 52, 269–324.
Wang, Z. Y., Alm, P., & Hakanson, R. (1995). Distribution and effects of pituitary adenylate cyclase activating peptide in the rabbit eye. Neuroscience, 69, 297–308.
Waschek, J. A. (2002). Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Developmental Neuroscience, 24, 14–23.
Yoshitomi, T., Yamaji, K., Ushikawa, H., & Ohnishi, Y. (2002). Effect of pituitary adenylate cyclase activating peptide on isolated rabbit iris sphincter and dilator muscles. Investigative Ophthalmology in Visual Science, 43, 780–783.
Acknowledgments
This work was supported by the Hungarian Science Research Fund (OTKA T046589, F 67830, K 72592, K 68476 and F 048908) and ETT439/2006.
Author information
Authors and Affiliations
Corresponding author
Additional information
Valera Gaal and Laszlo Mark made equal contribution to the present work.
Rights and permissions
About this article
Cite this article
Gaal, V., Mark, L., Kiss, P. et al. Investigation of the Effects of PACAP on the Composition of Tear and Endolymph Proteins. J Mol Neurosci 36, 321–329 (2008). https://doi.org/10.1007/s12031-008-9067-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-008-9067-5